内的细胞衰老调节与癌症相关的疼痛:一个新兴的治疗点?
Fabrizio Antonangeli1, Edoardo Arcuri2, Angela Santoni3,4
1Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Frontiers in immunology
|November 27, 2025
概括
细胞衰老在瘤微环境中导致神经炎症和癌症疼痛. 针对衰老细胞,可能与自然杀手 (NK) 细胞,可能提供新的缓解疼痛的策略.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 包括一个
研究的目的:
- 探索细胞衰老在内化中的作用.
- 为了研究衰老对神经炎症和癌症疼痛的贡献.
- 在疼痛管理的内化利基中识别潜在的治疗点.
主要方法:
- 关于衰老,TME,神经炎症和癌症疼痛的现有文献的综述.
- 在内化的背景下分析与衰老相关的分泌表型 (SASP).
- 探索免疫系统的作用,特别是自然杀手 (NK) 细胞在疼痛解决中的作用.
主要成果:
- 通过SASP,衰老可以促进神经炎症和与癌症相关的疼痛.
- 化位内的衰老细胞是潜在的治疗点.
- 免疫系统,包括NK细胞,在疼痛缓解中发挥作用.
结论:
- 细胞衰老与通过神经炎症的癌症疼痛的发展和维持有关.
- 向内心的衰老细胞是癌症疼痛管理的一个有希望的策略.
- 利用NK细胞为癌症患者的疼痛缓解提供了潜在的治疗途径.
关键词:
在 NK 细胞中, NK 细胞是最重要的.在 SASP 找 SASP癌症 癌症 癌症 癌症 癌症神经炎症是一种神经炎症.神经病变是一种神经病变.疼痛 疼痛 疼痛 疼痛衰老是一种老化.衰老溶解是一种衰老的过程.更多相关视频
06:05Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
961
08:57Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
465
相关概念视频
Nociception
33.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.0K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Stem Cell Niche
6.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.2K
Replicative Cell Senescence
4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
